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Autoimmune Basis of Sub Clinical 
Hypothyroidism in Pregnancy
Prakruti Dash and Rajlaxmi Tiwari
Abstract
Effects of overt hypothyroidism on pregnancy outcomes and fetal development 
are well established and treatment protocol is reputable. Subclinical hypothyroid-
ism poses a major health problem in pregnancy. Requirement of iodine increases 
in pregnancy as demand for synthesis of excess thyroid hormones is there during 
pregnancy. This is because of fetal dependency on maternal thyroid hormones 
till 12 weeks of gestation as fetal thyroid tissue is not matured enough to produce 
adequate hormones for the growing fetus. Hence, dietary iodine deficiency or 
intake of excess goitrogens in diet can be the major cause of overt and subclini-
cal hypothyroidism in pregnancy. Apart from this autoimmune basis of overt 
and sub clinical hypothyroidism is also equally important in pregnant women. 
Data accumulating shows presence of antibodies like anti TPO antibody (anti 
thyroperoxidase antibody) and anti Tg antibody (anti thyroglobulin antibody) in 
pregnancy which is associated with increased prevalence of overt and sub clinical 
hypothyroidism and aggravation of the symptoms associated with it. Studies also 
document that pregnancy related complications are more prevalent in presence of 
these autoimmune antibodies. Hence, management of subclinical hypothyroidism 
in pregnancy also differs in positive and negative cases of anti TPO antibody and 
anti-Tg antibody.
Keywords: sub-clinical hypothyroidism, pregnancy, obstetric outcome, 
autoimmunity, anti thyroperoxidase antibody (anti TPO antibody), 
anti-thyroglobulin antibody (anti Tg antibody), assisted fertilization
1. Introduction
Subclinical hypothyroidism (SCH), frequently observed in pregnancy is defined 
as high TSH with normal T4 and T3 level. The growing fetus is entirely dependent 
on mother thyroid hormones in the first 12 weeks; hence, any abnormalities during 
this period should be detected early and preventive measures initiated as decreased 
thyroid hormones is known to affect the mother and the fetus adversely.
Presence of anti-TPO antibody is a major risk factor for progression to overt 
hypothyroidism. After widespread use of fortified Iodine rich food and extra sup-
plementation of iodine in pregnancy, the knowledge and prevalence of autoimmune 
clinical and subclinical hypothyroidism with presence of various antibodies against 
thyroid tissues and metabolic factors gains more importance. Adverse obstetric and 
fetal outcomes particularly attributed to anti TPO antibodies makes its study even 
more clinically relevant. It is important to know the burden of anti-TPO antibody 
associated SCH cases due to their differences in management.
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1.1  Anatomical, physiological and biochemical adaption of thyroid gland to 
pregnancy
A palpable increase in size of the thyroid gland is observed in normal pregnancy 
which is also associated with a bruit [1]. There is an established increased renal 
clearance of iodide leading to increased thyroid iodide clearance with associated 
raised uptake of 131Iodide by the thyroid glands during pregnancy. This results in a 
relative iodine deficient status in the pregnant mother. There is also an increase in 
TBG (thyroid hormone binding globulin) for which total thyroxine exhibits a raised 
value but free thyroxine and free triiodothyronine (fT3) is mostly normal (Table 1).
1.2 Regulation of synthesis of thyroid hormones in pregnancy
The synthesis of thyroid hormones is regulated by HPT axis, i.e., hypothalamus-
pituitary-thyroid axis. The TRH released from hypothalamus acts positively on 
pituitary gland which releases TSH [1]. The TSH in turn stimulates the thyroid 
gland to synthesize and release T4 and T3. The thyroid gland gives negative 
feedback signal to hypothalamus and pituitary and thus excess of its synthesis is 
controlled and regulated. During pregnancy, in addition to the normal regulatory 
mechanisms, hCG also plays a significant role in regulation of thyroid hormone 
synthesis. hCG mostly the asialo-hCG fraction secreted from the placenta is known 
to have weak TSH simulating action and this plays an important role in maintaining 
the thyroid hormone levels, whose demand is increased in pregnancy due to fetal 
dependency on mother’s thyroid hormones almost exclusively up to 12 weeks of 
gestation and hCG acts by contributing to thyrotropic action of placenta. This also 
results in mild hyperthyroidism status in early pregnancy.
2. Anti-thyroid antibodies to thyroid antigens
2.1 Anti TPO antibody
Polyclonal antibodies directed against some epitopes of thyroperoxidase mol-
ecule are present in the blood of some healthy individuals and patients having auto 
immune thyroid disorders [1–3]. Anti-TPO antibodies from auto immune thyroid 
patients act as competitive inhibitors of enzymatic activity though those from 
healthy subjects are not seen to block thyroperoxidase [4, 5]. These antibodies 
mostly belong to IgG class, more often IgG1and IgG4 subtypes [6]. Prevalence of 
anti-TPO antibodies are more common than other anti-thyroid antibodies and more 
symbolic for thyroid hormone imbalance. Excess of oxidative stress markers in 
blood are seen with anti-TPO antibodies indicating it to be an inducer of oxidative 
Parameter Changes during pregnancy Normal values (up to)
TSH Reaches nadir during first trimester; then plateaus 4.0 mIU/L
T4 Increases in first trimester; then plateaus 150 ng/mL
fT4 Unchanged 30 pg/mL
T3 Increases in first trimester; then plateaus 2 ng/mL
fT3 Unchanged 4 pg/mL
Table 1. 
Normal levels of thyroid hormones and TSH in pregnancy [1].
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stress [7]. Apart from hypothyroid patients, anti-TPO antibodies are also detected 
in Graves’ disease patients. These antibodies possess the potential of crossing the 
placenta barrier to variable extent [8], though its effect on the neonate is debatable.
Few studies document that children born to anti TPO antibody positive preg-
nant women supposedly suffer from compromised motor and neuropsychological 
development [9]. There can be behavioral problems, attention deficit disorders in 
the off springs associated with raised titers of anti TPO antibody in the mothers 
during pregnancy [10]. Couple of literatures substantiate that children of anti TPO 
antibody positive mothers have lower brain to body mass ratio, decreased weight 
of brain and smaller head circumference compared to those of anti TPO antibody 
negative mothers [11, 12].
As the influence and outcome on off springs of increased anti TPO antibody 
concentration during pregnancy is of greater significance, longer follow up studies 
is required to gather more data on this important clinical aspect of neuropsycho-
logical development of the children.
2.2 Anti-thyroglobulin antibody
Polyclonal anti thyroglobulin (Tg) antibodies are found in the serum of healthy 
subjects whereas oligoclonal antibodies are seen in patients having auto immune 
thyroid disorders. It has been hypothesized that normal blood levels of Tg induce 
self-tolerance in T cells as low levels of antigens are usually responsible for develop-
ment of self-tolerance. But this self-tolerance is not seen in case of B cell activity 
resulting in healthy individuals having very low levels of anti-Tg antibodies which 
is usually below detection limits. Higher levels of Tg following tissue damage, or 
due to conformation alteration of the Tg molecule in presence of high iodine levels, 
or in presence of very high TSH levels, there is alteration in the titers of the anti-Tg 
antibody. The anti-Tg antibodies are predominantly of IgG4 though minor propor-
tions of IgA and IgM class are also seen. The functional consequence of anti-Tg 
antibodies is hitherto not known. Circulating antibodies were detected in healthy 
young subjects and in people >60 years of age to an extent of 10–15%. Presence 
of anti-Tg antibodies have been documented in auto immune thyroid disorders, 
Graves’ disease and in patients with non-thyroid immune disorders. These antibod-
ies like anti TPO antibodies can cross the placenta barrier but its effects are not very 
substantially known [1].
2.3 Thyroid hormone receptor antibodies
These antibodies bind to thyroid cell membrane at/near TSH receptor and mim-
ics the action of TSH as “occupied” receptor. This leads to excess thyroxin synthesis 
by the gland which escapes feedback control mechanisms. It is demonstrated 
frequently in Grave’s disease-also known as long acting thyroid stimulator (LATS) 
antibodies.
Excess of synthesis of thyroid hormones is known as hyperthyroidism and defi-
ciency leads to hypothyroidism. Both the conditions are associated with deleterious 
effects to various metabolic processes of the body [1].
3. Thyroid hormones and pregnancy
Thyroid hormones T4 and T3 affect almost every metabolic processes of the 
body. Pregnancy is considered to be a physiologically altered state of metabolism as 
the body tries to cater to the needs of the growing fetus. There is an increased need 
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of thyroid hormones in pregnancy as the developing fetus is completely dependent 
on maternal thyroid hormones till 12 weeks of gestation. Hence, the gland becomes 
over stimulated and hyperactive to secrete more T4 and T3 to meet the increased 
demand and this is brought about through hypothalamus-pituitary-thyroid axis 
regulatory mechanisms. Thyroxin and TBG (thyroid binding globulins) levels 
rise in pregnancy along with a simultaneous decrease in TSH (thyroid stimulating 
hormone) level [13]. A placental deiodinase enzyme also results in more thyroid 
hormone synthesis in pregnancy [14–16]. hCG is known to have a TSH simulat-
ing effect and hence attributes to raise the thyroid hormone synthesis to meet the 
increased demand via its thyrotrophic effect [17]. Absolute fetal dependency on 
mother’s thyroid hormones can result in adverse obstetric and fetal outcome if 
the increased demand for T4 and T3 is not met adequately in the first 12 weeks of 
gestation [18]. There has also been documented evidences that proper placental 
development is also dependent on thyroid hormones and lack of it can result in 
improper placenta formation [19] with adverse obstetric outcomes like abruptio 
placentae, preeclampsia, miscarriages, preterm delivery, low birth weight (LBW), 
IUGR (intrauterine growth retardation) and small for gestational age babies (SGA) 
[20–22]. Impaired intellectual development of off springs of hyper/hypothyroid 
mothers has also been documented [23].
3.1 Thyroid hormones and its effects on obstetric outcome
Various studies have registered in their findings that placenta has strong affinity 
for T3 and is dependent on thyroid hormones for its growth. Triiodothyronine/
T3 is plays a significant role in placental trophoblastic growth by its likely effect on 
growth factors like EGF (epidermal growth factor) and hormone like 17 beta estra-
diol [19, 24, 25]. Small for gestational age babies (SGA) and intra uterine growth 
retardation of fetus (IUGR) are most likely results of impaired growth of placental 
trophoblasts [26, 27]. Fetal thyroid hormones have been found to be decreased in 
IUGR babies compared to gestation matched normal fetal serum. Inflammation 
associated with impaired uteroplacental circulation are registered to be causative 
factors for development of serious disorders like eclampsia and preeclampsia in 
pregnancy. These situations are also documented to be associated with increased 
oxidative stress by various studies [28]. Hence various studies now put inflam-
mation under major focus in development of preeclampsia and pre-term labor in 
pregnancy. Thyroid hormones act on DNA and regulate expression of various genes 
which also includes genes associated with inflammation. As inflammation is now 
considered to be an important causative factor for development of pre-eclampsia, 
thyroid hormones are also corroborated by various studies to be responsible for 
this [29]. Analysis of maternal and cord blood has validated this hypothesis and 
revealed a low T4 with raised TSH level in preeclampsia cases which has also been 
linked with placental inadequacy.
Various studies have also found an association of gestational diabetes mellitus 
(GDM) with impaired thyroid status. Inverse correlation between metformin and 
TSH value further strengthens this association. Thus, screening of all pregnant 
women for thyroid function along with anti TPO antibody measurement has been 
advised by many studies, particularly in “at risk “cases of GDM [30–33]. Both 
thyroid dysfunction and diabetes mellitus are known to adversely affect obstetric 
and fetal outcome and now gradually gathering data proves that very often both 
the conditions coexist in pregnancy depicting an association between them and 
hence early screening, intervention and timely management is advocated by various 
studies [34–37].
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3.2 Pregnancy and clinical/subclinical hypothyroidism
The need for iodine increases in pregnancy (daily requirement of  
iodine −150–200 μg/day, 250 μg/day in pregnancy) leading to an iodine deficient 
status if not adequately supplemented. Apart from iodine deficiency, the other most 
common factor for thyroid hormone deficiency has been attributed to anti-TPO 
antibodies. Hypothyroidism is registered to be more prevalent in Asian countries 
compared to their Western counterparts. As such thyroid disorders have wide 
geographical variations attributed to dietary factors, level of various goitrogens in 
diet and their consumption level, deficiencies of micronutrients like selenium, iron 
and most importantly iodine. Autoimmune thyroid diseases are also more prevalent 
in Asian countries and accumulating literatures suggest it to be more substantial in 
Indian population with greater prevalence of anti TPO antibody positivity.
High TSH level with normal T4 level is known as subclinical hypothyroidism 
(SCH). Subclinical hypothyroidism is one of the most common type of thyroid 
dysfunction that is found to be associated with pregnancy [38, 39]. The increased 
need of thyroid hormones to meet the extra demand by the growing fetus in the 
first 12 weeks of gestation is dealt by hCG due to its thyrotrophic action as discussed 
earlier and also via hypothalamus-pituitary-thyroid axis regulation which usually 
results in small painless enlargement, i.e., goiter formation in pregnant women [1]. 
This also results in increased need of iodine in pregnancy.
Hence, endemic areas of iodine deficiency have shown a higher prevalence of 
clinical or subclinical hypothyroidism in general and in particular in pregnant 
women. Because of increased thyroid hormone production, increased renal iodine 
excretion, and fetal iodine requirements, dietary iodine requirements are higher 
in pregnancy than they are for non-pregnant adults. The requirement of iodine 
is 250 μg/day in pregnancy. Recommendation by American Thyroid Association 
(ATA) is women who are planning pregnancy or currently pregnant, should supple-
ment their diet with a daily oral supplement that contains 150 μg of iodine in the 
form of potassium iodide [40]. This should optimally start 3 months in advance of 
planned pregnancy.
3.3 Hypothyroidism and autoimmunity in pregnancy
However, apart from iodine deficiency, the other most significant cause of 
hypothyroidism in recent times is presence of anti thyroperoxidase antibody, i.e., 
anti TPO antibody and anti Tg (anti thyroglobulin) antibody in the serum. The thy-
roperoxidase enzyme as described above is highly essential for oxidation of trapped 
iodine and its incorporation into tyrosine molecule for synthesis of thyroxin. Anti 
TPO antibody destroys the thyroperoxidase enzyme and hence prevents the iodin-
ation of tyrosine molecule and overall synthesis of thyroxin is hampered resulting 
in hypothyroidism. This autoimmune basis of hypothyroidism is now more relevant 
after iodine deficiency has been tackled by fortification of food products with 
iodine/with iodine supplementation as potassium iodide. In pregnancy, immune 
regulatory cytokines and cells are present in the mother’s circulatory system and 
accumulate in the decidua and can modify autoimmune responses influencing the 
symptoms of autoimmune disease [41].
Presence of anti-TPO antibody is a major risk factor for progression to overt 
hypothyroidism. Various studies reveal a prevalence of 2–17% of euthyroid preg-
nant women being anti-TPO antibody positive. Still data from Indian scenario is 
extremely limited. TPO antibodies are able to cross the placenta. At the time of 
delivery, cord blood anti TPO Ab levels strongly correlate with third-trimester 
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maternal anti TPO antibody concentrations [8]. However, concrete documentation 
of maternal passage of either anti TPO antibodies or anti Tg antibodies affecting the 
fetal thyroid function is still debatable [9–12].
It has been documented that euthyroid pregnant women who are positive for 
thyroid peroxidase autoantibody (anti TPO antibody) also are at increased risk 
of various complications of pregnancy including miscarriage, preterm birth, 
pregnancy-induced hypertension (PIH), intrauterine death (IUD), and intrauterine 
growth retardation (IUGR) [42, 43].
A number of etiologies have been hypothesized as the cause of the relationship 
between various pregnancy related complications like miscarriage, IUGR, pre-
eclampsia, pre term delivery and autoimmune thyroid antibodies. To enumerate a 
few: (a) prior presence of a restrained degree of hypothyroidism, (b) thyroid anti-
bodies reflecting an immunological imbalance inclining towards auto immunity in 
the pregnant female, (c) direct effects of thyroid autoantibodies on the placenta or 
the fertilized ovum. The above hypotheses have been corroborated by the observa-
tion of higher levels of TSH within the normal range noted in various meta-analysis 
studies indicating a milder degree of thyroid failure in euthyroid pregnant women 
with thyroid auto antibodies positivity [41, 44–46].
3.4 Autoimmune hypothyroidism and development of goiter in pregnancy
Pregnancy is considered to be a goitrogenic status, particularly in the Iodine 
deficiency scenario. Increased need of thyroid hormones, TSH simulating actions of 
beta HCG with super added iodine deficiency actually leads to volumetric increase 
in the gland and not just vascular engorgement which also has been biochemically 
corroborated by observations of high serum Thyroglobulin levels, more T3 secre-
tion and small rise in basal TSH level at delivery. Studies supports that there is 
actual goiter formation in pregnancy which can be tackled to a measurable extent 
by adequate iodine supplementation [47].
Presence of anti TPO antibodies is mostly associated with Hashimoto’s thyroid-
itis, Graves’ disease, nodular goiter and thyroid carcinoma [1]. Anti TPO antibody 
positivity in pregnancy is mostly associated with overt or subclinical hypothyroid-
ism during pregnancy sometimes associated with a goiter which is often painless. 
Post-delivery, there are incidences of postpartum thyroiditis with a milder form of 
Graves’ disease lacking the typical symptomatic features which after a few months, 
changes to hypothyroidism and development of small painless goiter [1, 48, 49].
4. Reference limits for diagnosis of hypothyroidism in pregnancy
It is important to know the burden of anti-TPO antibody associated SCH cases 
due to their differences in management. This is even more important in case of 
pregnant women as presence of anti TPO antibody makes them more vulnerable to 
clinical hypothyroidism and hence its detection at early pregnancy helps in its better 
management. The management for pregnant women with subclinical hypothyroid-
ism with anti TPO Ab positive and negative differs from each other.
Setting the reference limits for thyroid hormones and TSH in pregnancy is a 
debatable fact due to different laboratories giving different values and there is gross 
geographical variation too. Guidelines of the American Thyroid Association for the 
Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum 
(ATA 2011) recommends a trimester specific range of TSH in pregnancy which is 
lower than in normal adult, i.e., first trimester: 0.1–2.5 mIU/L, second trimester: 
0.2–3.0 mIU/L, third trimester: 0.3–3.0 mIU/L [40]. However, the recent guidelines 
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of ATA recommend “When available, population- and trimester-specific refer-
ence ranges for serum TSH during pregnancy should be defined by a provider’s 
institute or laboratory and should represent the typical population for whom care 
is provided. Reference ranges should be defined in healthy anti TPO Ab-negative 
pregnant women with optimal iodine intake and without thyroid illness. If internal 
or transferable pregnancy-specific TSH reference ranges are not available, an upper 
reference limit of ∼4.0 mIU/L may be used” (ATA-2017) [50]. In the absence of 
accredited trimester specific reference ranges for thyroid hormones and TSH levels 
in pregnancy in India, the current practice is to use the reference limits set by ATA 
as per 2017 guidelines [50].
4.1 Management of overt and subclinical hypothyroidism in pregnancy
Recent guidelines of ATA recommends regular monitoring of thyroid status in 
women with overt and subclinical hypothyroidism (treated or untreated) or those 
at risk for hypothyroidism (e.g., patients who are euthyroid but anti TPO antibody 
or anti Tg antibody positive, post-hemithyroidectomy, or treated with radioactive 
iodine) with a serum TSH measurement approximately every 4 weeks until comple-
tion of second trimester and at least once near 30 weeks gestation [50]. Sub clinical 
hypothyroidism in anti TPO antibody negative and positive cases in pregnancy are 
differently managed with levothyroxine (LT4) as per the recommendations of ATA 
2017 guidelines [50] (Table 2).
5. Thyroid auto antibodies and assisted fertilization
Recently, some researchers speculated that assisted conception in women posi-
tive for anti-thyroid antibodies had poor outcome of in vitro fertilization, even if 
they were euthyroid. Studies do document that anti thyroid antibodies positive 
patients had low fertilization rate, implantation rate, and pregnancy rate and 
high abortion rate. Regarding the question how these antibodies interfered with 
fertilization, embryo development as well as implantation potential still remains 
unanswered. The hypothesis is that the antibodies may bind to either the surface 
of the egg and/or embryo and interfere with fertilization and subsequent embryo 
TSH value T4/T3 Anti 
TPO
Therapy with LT4
1 Within the pregnancy-specific reference 
range or <4.0 mIU/L (if specific reference 
range unavailable)
Normal Negative Not recommended
2 TSH >10.0 mU/L Normal Negative Strong 
recommendation
3 TSH >2.5 mU/L and below the upper limit of 
the pregnancy-specific reference range
Normal Positive Weak recommendation
4 TSH greater than the upper limit of the 
pregnancy-specific reference range but 
below 10.0 mU/L
Normal Negative Weak recommendation
5 TSH greater than pregnancy-specific 
reference range or >4.0 mIU/L (if specific 
reference range unavailable)
Normal Positive Strong 
recommendation
Table 2. 
Recommendations by ATA 2017 guidelines regarding management of sub clinical hypothyroidism in pregnancy [50].
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development. Alternatively, the presence of the auto antibodies in the endome-
trial tissue may exert detrimental effect on embryo implantation leading to early 
pregnancy loss [51–54].
6. Conclusion
More and more evidences worldwide have pointed towards anti TPO antibody 
to be associated with clinical and subclinical hypothyroidism with adverse obstetric 
and fetal outcomes. As the management differs for subclinical hypothyroidism 
in anti TPO antibody positive and negative pregnant women hence more stud-
ies should be undertaken pertinent to different geographical areas regarding the 
prevalence of autoantibodies and their effect on pregnancy and on the off springs in 
the long term. The trimester specific reference ranges for different areas should also 
be specified with larger cohort of studies particularly for countries like India where 
there are wide geographical and ethnic variations. The area where there is severe 
lacking of data with respect to India is regarding the effects of autoimmune sub-
clinical hypothyroidism on the obstetric, fetal outcomes and most importantly on 
the off springs in the long run. Hence, longer follow-up studies with larger cohorts 
is necessary to gather more evidences regarding this important endocrinal disorder 
in pregnancy in India.
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